1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising use of viral vectors in several treatments such as cancer demands developments in plasmids and vectors
5.1.1.2. Awareness on the benefits of gene therapy
5.1.1.3. Increase in funding for research and development activities
5.1.2. Restraints
5.1.2.1. Limited trained professionals and the complexity of the manufacturing process
5.1.3. Opportunities
5.1.3.1. Emerging demand for synthetic genes
5.1.3.2. Approval of gene therapy products from the FDA and other governing bodies
5.1.4. Challenges
5.1.4.1. Ethical concern, logistical issues, and associated cost
5.2. Cumulative Impact of COVID-19

6. Viral Vector & Plasmid DNA Manufacturing Market, by Cell Line
6.1. Introduction
6.2. In-vitro
6.3. In-Vivo

7. Viral Vector & Plasmid DNA Manufacturing Market, by Type
7.1. Introduction
7.2. Adeno-Associated Virus
7.3. Adenovirus
7.4. Lentivirus
7.5. Plasmid DNA

8. Viral Vector & Plasmid DNA Manufacturing Market, by Transfection
8.1. Introduction
8.2. Stable Transfection
8.3. Transient Transfection

9. Viral Vector & Plasmid DNA Manufacturing Market, by Indication
9.1. Introduction
9.2. Cancer
9.3. Genetic Disorder
9.4. Infectious Disease

10. Viral Vector & Plasmid DNA Manufacturing Market, by Workflow
10.1. Introduction
10.2. Downstream Processing
10.2.1. Fill-finish
10.2.2. Purification
10.3. Upstream Processing
10.3.1. Vector Amplification & Expansion
10.3.2. Vector Recovery/Harvesting

11. Viral Vector & Plasmid DNA Manufacturing Market, by Application
11.1. Introduction
11.2. Antisense & RNAi
11.3. Cell Therapy
11.4. Gene Therapy
11.5. Vaccinology

12. Viral Vector & Plasmid DNA Manufacturing Market, by End User
12.1. Introduction
12.2. Biotech Companies
12.3. Research Institutes

13. Americas Viral Vector & Plasmid DNA Manufacturing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand

15. Europe, Middle East & Africa Viral Vector & Plasmid DNA Manufacturing Market
15.1. Introduction
15.2. France
15.3. Germany
15.4. Italy
15.5. Netherlands
15.6. Qatar
15.7. Russia
15.8. Saudi Arabia
15.9. South Africa
15.10. Spain
15.11. United Arab Emirates
15.12. United Kingdom

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. ABL Inc.
17.2. Batavia Biosciences B.V.
17.3. BioNTech IMFS GmbH
17.4. Biovian Oy
17.5. c-LEcta GmbH
17.6. Cell and Gene Therapy Catapult
17.7. Cevec Pharmaceuticals GmbH
17.8. Cobra Biologics Limited
17.9. Creative Biogene
17.10. FinVector Vision Therapies
17.11. FUJIFILM Diosynth Biotechnologies Inc.
17.12. GE Healthcare
17.13. GeneOne Life Science, Inc.
17.14. Genezen Laboratories
17.15. Kaneka Eurogentec S.A.
17.16. Lonza Group AG
17.17. Merck KGaA
17.18. Miltenyi Biotec GmbH
17.19. Novasep Inc.
17.20. Sirion-Biotech GmbH
17.21. Spark Therapeutics Inc.
17.22. Thermo Fisher Scientific Inc.
17.23. uniQure N.V.
17.24. Vigene Biosciences, Inc.
17.25. Wuxi AppTec Co., Ltd.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2020 VS 2026 (%)
FIGURE 4. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2020 VS 2026 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2026
FIGURE 6. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 8. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, 2018-2026 (USD MILLION)
FIGURE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 10. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 11. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2026
FIGURE 13. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2020 VS 2026 (%)
FIGURE 22. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2020 VS 2026 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2026
FIGURE 24. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 29. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2026
FIGURE 31. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2020 VS 2026 (%)
FIGURE 38. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2020 VS 2026 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2026
FIGURE 40. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 52. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 53. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2026
FIGURE 55. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, 2018-2026 (USD MILLION)
FIGURE 56. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 57. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2026 (USD MILLION)
FIGURE 58. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 59. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2026 (USD MILLION)
FIGURE 60. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 61. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2026 (USD MILLION)
FIGURE 62. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 63. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 64. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2026
FIGURE 66. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2026 (USD MILLION)
FIGURE 67. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 68. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 69. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 70. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 86. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 87. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 88. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 89. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 90. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 91. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 92. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 93. QATAR VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 94. RUSSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 95. SAUDI ARABIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 96. SOUTH AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 97. SPAIN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 98. UNITED ARAB EMIRATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 99. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 100. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: FPNV POSITIONING MATRIX
FIGURE 101. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY REGION, 2018-2026 (USD MILLION)
TABLE 27. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 28. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 31. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 32. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 33. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. QATAR VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. RUSSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. SAUDI ARABIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. SOUTH AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. SPAIN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. UNITED ARAB EMIRATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: SCORES
TABLE 64. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 65. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 66. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: RANKING
TABLE 67. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 68. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 69. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 70. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 71. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 72. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 73. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: LICENSE & PRICING

Companies Mentioned

ABL Inc.
Batavia Biosciences B.V.
BioNTech IMFS GmbH
Biovian Oy
c-LEcta GmbH
Cell and Gene Therapy Catapult
Cevec Pharmaceuticals GmbH
Cobra Biologics Limited
Creative Biogene
FinVector Vision Therapies
FUJIFILM Diosynth Biotechnologies Inc.
GE Healthcare
GeneOne Life Science, Inc.
Genezen Laboratories
Kaneka Eurogentec S.A.
Lonza Group AG
Merck KGaA
Miltenyi Biotec GmbH
Novasep Inc.
Sirion-Biotech GmbH
Spark Therapeutics Inc.
Thermo Fisher Scientific Inc.
uniQure N.V.
Vigene Biosciences, Inc.
Wuxi AppTec Co., Ltd.